Comprehensive insights into pathogen distribution, clinical features, and outcomes in pediatric severe pneumonia
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2025.1681950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Chunyun Fu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science Laboratory, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Hauptthemen laut MEDLINE: Pneumonia. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Pediatric severe pneumonia is a life-threatening condition with high incidence and mortality rates. This study provides a comprehensive analysis of pathogen distribution, infection patterns, clinical manifestations, and prognosis associated with the disease.
Methods
This study involved 227 children with severe pneumonia and a control group of 227 with non-severe pneumonia. Targeted next-generation sequencing (tNGS) was applied to identify respiratory pathogens.
Results
The median age of children with severe pneumonia was 12 months, markedly younger than the median of 24 months in the non-severe group. The tNGS identified suspected pathogenic microorganisms in 99.12% of the severe pneumonia cases, with predominant pathogens including Human Respiratory Syncytial Virus (33.92%), Cytomegalovirus (33.04%), Mycoplasma pneumoniae (24.67%), and Rhinovirus (23.79%). Clinically, those with severe pneumonia exhibited markedly elevated procalcitonin levels and an increased prevalence of fever, wheezing, and dyspnea, alongside longer hospital stays, more protracted fever, and significantly higher hospitalization costs compared to their non-severe counterparts. Complications, including respiratory and other systemic issues, occurred in 96.04% and 59.47% of the severe pneumonia group, respectively, both significantly higher than in the non-severe pneumonia group; 99.12% required respiratory support and significantly more (56.83%) were admitted to the ICU, with a 9.69% incidence of poor outcomes.
Conclusion
Children with severe pneumonia tend to be younger than those with non-severe pneumonia. While significant differences are observed in the distribution of pathogens, complications, clinical manifestations, and prognosis between the two groups, no significant differences are noted in the number of infecting microorganisms or infection patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Science Laboratory, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Pediatric Respiratory Medicine, Children's Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Division of Neonatology, Department of Pediatrics, University of Miami Miller School of Medicine and Holtz Children's Hospital, Jackson Health System, Miami, FL, United States.
Zitieren
APA
Fu, C., Lu, X., Zhao, J., Huang, Y., Huang, Q., Mo, L., Feng, Y., Tang, W., Lu, C., Li, M., Wei, Y., Chen, R., Liu, G., Ruan, J., Huang, H., Li, Q., & Tan, J. (2026). Comprehensive insights into pathogen distribution, clinical features, and outcomes in pediatric severe pneumonia. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1681950
Vancouver
Fu C, Lu X, Zhao J, Huang Y, Huang Q, Mo L, et al. Comprehensive insights into pathogen distribution, clinical features, and outcomes in pediatric severe pneumonia. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2025.1681950
BibTeX
@article{Fu2026,
author = {Fu, Chunyun and Lu, Xiangjun and Zhao, Jiangyang and Huang, Ya and Huang, Qiang and Mo, Lishai and Feng, Yanhua and Tang, Wenting and Lu, Cuihong and Li, Mengjun and Wei, Yubing and Chen, Ruting and Liu, Guangbing and Ruan, Jialing and Huang, Huiping and Li, Qifei and Tan, Jie},
title = {Comprehensive insights into pathogen distribution, clinical features, and outcomes in pediatric severe pneumonia},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2025.1681950}
}
EUVIMED